Pilot Study to Determine Biodistribution of MM-398 and Feasibility of Ferumoxytol as a Tumor Imaging Agent

Conditions:   Solid Tumors;   ER/PR Positive Breast Cancer;   Triple Negative Breast Cancer;   Metastatic Breast Cancer With Active Brain Metastasis
Intervention:   Drug: Ferumoxytol followed by MM-398
Sponsor:   Merrimack Pharmaceuticals
Recruiting - verified March 2016

from #ORL via xlomafota13 on Inoreader http://ift.tt/1XMzA0y
via IFTTT